Four young women had an extremely rare, aggressive and fatal form of ovarian cancer. They where not expected to live much longer as there was no standard treatment. These women, living in different countries, asked their doctors to try using new immunotherapy drugs for the treatment of the cancer.
https://williamscancerinstitute.com/wp-content/uploads/2021/04/Immunotherapy-for-cancer.png4951200adminhttp://williamscancerinstitute.com/wp-content/uploads/2021/05/Williams-Cancer-Institute-Logo2.pngadmin2018-06-20 15:25:242021-06-25 16:21:31Women Told Immunotherapy Would Not Cure Cancer, Doctors Were Wrong
Researchers in North Carolina published data on a injectable hydrogel drug delivery system for cancer, further supporting the work that we are doing. Over a year ago, we began using a hydrogel, combined with immunotherapy agents and Celebrex, injected directly into tumors.
https://williamscancerinstitute.com/wp-content/uploads/2021/06/hydrogel-for-cancer-treatment.png4951200adminhttp://williamscancerinstitute.com/wp-content/uploads/2021/05/Williams-Cancer-Institute-Logo2.pngadmin2018-06-19 12:11:062021-06-25 16:21:17Hydrogel Drug Delivery System For Cancer Treatment